Development pharmaceutics

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/QWP/155/96
Effective from01/07/1998
KeywordsDevelopment pharmaceutics, formulation, quality, product, dosage form
DescriptionThis document provides guidance on the data from pharmaceutical development studies required for marketing authorisation. It aims to facilitate the application of Part II, sections A.4 of the Annex to Directive 75/318/EEC, as amended. Read together with the annex on decision trees for selection of sterilisation methods.

Related content

How helpful is this page?

Average rating:

 Based on 41 ratings

Add your rating:

See all ratings
8 ratings
8 ratings
8 ratings
8 ratings
9 ratings

Tell us more